Searchable abstracts of presentations at key conferences in endocrinology

ea0029p864 | Endocrine tumours and neoplasia | ICEECE2012

Circadian rhythm of prolactin release in patients with breast cancer

Krawczyk M. , Gasinska T.

Background: A number of studies have evaluated the association between prolactin (PRL) and breast cancer risk, but some results have been inconsistent.The aim of this study was to investigate, if the circadian rhythm of PRL was maintained in pre- and post-menopausal patients with breast cancer and if there is a correlation between serum PRL level, serum concentration of insulin-like growth factor 1 (IGF1), tumor staging and expression of estrogen, proges...

ea0007p263 | Clinical case reports | BES2004

A case of the pituitary resistance to thyroid hormone successfully treated with bromocriptine

Zieleniewski W , Kolodziej-Maciejewska H , Krawczyk Z

Pituitary resistance to thyroid hormone is a very rare cause of hyperthyroidism. It is characterized by normal, or elevated TSH concentration with high concentration of thyroxine and triiodothyronine.Here, we present a case of a 24-year-old woman who suffered from mild thyrotoxicosis and diffuse goiter for ten years. For several years she was under treatment with methimazole, but without any significant improvement, apart from the enlargement of the thyr...

ea0063p438 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

A case of late recognition of the malignant cause of chronic pancreatitis

Christidis Grigorios , Garaiman Alexandru , Holz Robert , Krawczyk Marcin , Lammert Frank

Pancreatic neuroendocrine tumors constitute a disease with steadily increasing prevalence worldwide in part owing to the increased detection of early stage disease. Here we present the case of a 49 year old male patient, who was admitted with clinical, laboratory and CT features of acute pancreatitis. A clear cause for the pancreatitis could not be detected. Excessive alcohol intake was reliably denied, and the patient did not take any drugs. Gallbladder and bile ducts were in...

ea0063p613 | Diabetes, Obesity and Metabolism 2 | ECE2019

A common but forgotten cause of electrolyte disturbances in patients with cachexia

Christidis Grigorios , Garaiman Alexandru , Holz Robert , Krawczyk Marcin , Lammert Frank

Fluid and electrolyte disturbances are a challenging problem of inpatients, especially in those subpopulations, in whom the electrolyte imbalance is involved in the pathogenesis of the primary disease. Here we present the case of a 58 year old woman, with ongoing alcohol abuse on a daily basis, who was admitted with progressive fatigue and dysphagia. At the admission BMI was 17.8 kg/m2, and the patient presented deficiency of vitamins A, B, and D. The diagnostic pro...

ea0049ep775 | Developmental endocrinology | ECE2017

GH influences plasma fasting adropin concentration in patients with turner syndrome

Wikiera Beata , Krawczyk Magdalena , Noczynska Anna , Daroszewski Jacek

Background: Increased adiposity and insulin resistance are conditions frequently observed nowadays. Many hormones are involved in the pathogenesis of the condition but therapeutic options we can offer to the patients are still scant. Each newly discovered peptide give us hope. Adropin (Ad) is a newly discovered metabolic hormone involved in energy homeostasis. This homeostasis is frequently disturbed in patient with Turner Syndrome (TS). Patient with Turner syndrome are unique...

ea0035p93 | Bone and Osteoporosis | ECE2014

The effects of recombinant human TSH on selected bone markers in the follow-up of patients treated for differentiated thyroid carcinoma

Krawczyk-Rusiecka Kinga , Skowronska-Jozwiak Elzbieta , Wojciechowska-Durczynska Katarzyna , Glowacka Ewa , Lewinski Andrzej

Introduction: TSH seems to play direct role in bone metabolism. TSH receptors are expressed on osteoblasts and osteoclast precursors. Osteocalcin (OC) is well known marker of bone formation, whereas collagen type I crosslinked C-telopeptide I (CTX) is marker of bone resorption. Sclerostin is a protein, recently found to inhibit bone formation, while parathormone (PTH) inhibits sclerostin production. The aim of the study was to estimate sclerostin, OC, CTX and PTH levels after ...

ea0029p179 | Bone & Osteoporosis | ICEECE2012

Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels

Skowronska-Jozwiak E. , Krawczyk-Rusiecka K. , Lewandowski K. , Adamczewski Z. , Bienkiewicz M. , Lewinski A.

Sclerostin, a product of a SOST gene, is a protein expressed by osteocytes that inhibits osteoblastic bone formation. Several hormones including PTH and glucocorticosteroids and have been suggested as possible regulators of sclerostin production. The influence of thyroid hormones on sclerostin synthesis has not been investigated so far. The aim of the study was to evaluate sclerostin concentrations in patients before and after treatment of thyrotoxicosis.<p class="abstext"...

ea0022p449 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Pheochromocytomas in the RET protooncogene mutations carriers

Hasse-Lazar Kornelia , Krawczyk Aleksandra , Szpak-Ulczok Sylwia , Pawlaczek Agnieszka , Ziaja Jacek , Jarzab Barbara

Mutations in the RET protooncogene cause familial cases of medullary thyroid cancer, which in some cases coexists with pheochromocytoma and primary hyperparathyreoidism as the MEN2A syndrome.Aim of the study: Evaluation of frequency of pheochromocytomas and their clinical course in the RET protooncogene mutations carriers.Material: One hundred and seventy nine patients, among them 109 probands and 70 family members in...

ea0022p861 | Thyroid | ECE2010

Elastography based on tissue Doppler in the diagnosis of thyroid nodules: a pilot study

Adamczewski Zbigniew , Krawczyk-Rusiecka Kinga , Dedecjus Marek , Brzezinski Jan , Lewinski Andrzej

Objective: Aiming at the highest specifity in differentiating benign from malignant thyroid nodules effects in new diagnostics developments. Recent technologies such as elastography enable determination of tissue stiffness difference between focal lesions and surrounding thyroid tissue – reference tissue. This method is based on quantifying the stiffness of the lesion – the malignant changes show decreased elasticity when compared to adjacent tissue. Tissue Doppler u...

ea0016p278 | Endocrine tumours | ECE2008

The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in large intestine metastases into liver

Debski Marcin , Kornasiewicz Oskar , Stepnowska Marta , Szalas Anna , Krawczyk Marek , Bar-Andziak Ewa

Type 1 iodothyronine deiodinase (D1) is responsible for the conversion of thyroxin (T4) into tri-iodothyronine (T3). The enzyme is mainly present in thyroid, liver and kidneys.There is strong evidence that the metabolism of thyroid hormones is disturbed in some neoplasmatic tissues. However there are only few available data about D1 enzymatic activity in liver tumors.The aim of this study was to estimate the e...